Background
==========

Bloodstream infections are characterized by high mortality and morbidity \[[@b1-medscimonit-22-161]\]. Bacterial infections may spread via the bloodstream with the consequent development of systemic inflammatory response syndrome (SIRS), and even sepsis, which is a widespread and uncontrolled inflammatory response and a major cause of morbidity and mortality \[[@b2-medscimonit-22-161]\]. Currently, the most important bloodstream infections are caused by gram-negative and gram-positive bacteria. The clinical signs and symptoms are almost indistinguishable between these 2 types of infection \[[@b3-medscimonit-22-161]\]. Hence, in the majority of these bloodstream-infected patients, the causative infectious agents cannot be identified due to the nonspecific signs and symptoms \[[@b4-medscimonit-22-161]\]. Therefore, it is customary to start empirical broad-spectrum antimicrobial therapy \[[@b5-medscimonit-22-161]\], but this contributes to the emergence of drug-resistant strains of bacteria and leads to increased medical costs. Several studies showed that early use of selective antibiotics can effectively reduce the mortality of bloodstream infection \[[@b6-medscimonit-22-161]--[@b8-medscimonit-22-161]\]; therefore, the differential diagnosis of bloodstream infections as early as possible to assist the selective use of antibiotics is particularly important during clinical trials \[[@b9-medscimonit-22-161],[@b10-medscimonit-22-161]\].

Early diagnosis of bloodstream infections remains problematic. Although the "gold standard" of bacterial detection is blood culture, in nearly half of neutropenic fever episodes in children with cancer, no microorganisms were isolated \[[@b11-medscimonit-22-161]\]. Moreover, lower positive rate, higher false-negative and false-positive rates, and longer detection period limit the diagnostic value of blood culture \[[@b12-medscimonit-22-161],[@b13-medscimonit-22-161]\]. Traditional diagnostic indicators of blood infection -- white blood cell count (WBC), erythrocyte sedimentation rate, and body temperature -- are not sufficiently sensitive and specific to meet clinical needs \[[@b14-medscimonit-22-161],[@b15-medscimonit-22-161]\]. Molecular biology is a modern diagnostic approach to bloodstream infections that warrants increased research attention \[[@b16-medscimonit-22-161]\]. Overtreatment of these patients without a confirmed bacterial infection results in increased risk of bacterial resistance. The specificity and sensitivity of tests for bloodstream infection are limited. In an attempt to improve diagnosis of bloodstream infections, biomarkers such as pro-inflammatory cytokines and acute-phase proteins have become additional diagnostic tools to optimize and expedite the clinical diagnosis.

For the correct diagnosis of bloodstream infections, use of inflammatory mediators provides another means to assist in the diagnosis of infection and predict disease outcome. Thus, more targeted selection of antibiotic treatment can reduce the incidence of drug-resistant pathogens and prevent deterioration of the patient's condition. Circulating inflammatory mediators, especially C-reaction protein (CRP), procalcitonin (PCT), and interleukin (IL)-6, have been suggested to be predictors of systemic microbial bloodstream infection \[[@b17-medscimonit-22-161]--[@b20-medscimonit-22-161]\]. However, the early cellular response to gram-negative and gram-positive bacteria is still unclear, and little is known about the differentiation between gram-positive and gram-negative bacterial infections using circulating inflammatory mediators.

Clinical data on the detection of pathogens in patients with bloodstream infections show that the highest detection rates of gram-positive and gram-negative bacteria were in *Staphylococcus aureus* (*S. aureus*) and *Escherichia coli* (*E. coli*), respectively \[[@b21-medscimonit-22-161],[@b22-medscimonit-22-161]\]. More than 50% of sepsis was caused by *S. aureus* and *Staphylococcus epidermidis* \[[@b23-medscimonit-22-161]\]. *S. aureus* is widely present in air and water, as well as in human and animal excrement. *S. aureus* is present on more than 50% of healthy human skin \[[@b24-medscimonit-22-161]\], and it is also one of the most common pathogens causing hospital-acquired and community-acquired infections. It is the cause of a variety of human diseases, including sepsis, endocarditis, food poisoning, and toxic shock syndrome \[[@b25-medscimonit-22-161]\]. With the widespread use of antibiotics, resistant strains of *S. aureus* have been rapidly increasing, and the problem of methicillin-resistant *Staphylococcus aureus* (MRSA) has caused worldwide concern \[[@b26-medscimonit-22-161],[@b27-medscimonit-22-161]\]. *E. coli* is the most important human intestinal flora of parasites. It is also the most common gram-negative bacilli causing infectious diseases, it is the main pathogen in a variety of common bacterial infections in humans, and is among the top 3 pathogens causing bloodstream infections, abdominal bowel tract infections, neonatal meningitis, and bacterial diarrhea in travelers \[[@b28-medscimonit-22-161],[@b29-medscimonit-22-161]\]. Drug resistance of *E. coli* continues to increase, has become the human body's largest repository of resistant genes, and is the subject of worldwide research \[[@b30-medscimonit-22-161]\].

The present study was designed to focus on *S. aureus* and *E. coli* bloodstream infections, and to compare the induction of PCT, CRP, and IL-6 to discriminate between gram-negative and gram-positive infections. We also compared the induction of inflammatory mediators in infected mice after injection of *S. aureus* ATCC 25923 or *E. coli* ATCC 25922 as models to discriminate between gram-negative and gram-positive bacterial blood stream infections.

Material and Methods
====================

Animals
-------

Specific-pathogen-free male ICR mice purchased from the Beijing Sibeifu Experimental Animal Center, weighing between 25 and 28 g, were used to establish bloodstream infection models. They were kept in a specific-pathogen-free facility. Each mouse was only used for 1 experiment. All mice were acclimated for 1 week before the experiment. Mice were maintained with humane care in accordance with the "Guide for the Care and Use of Laboratory Animals" approved by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 86-23, revised 1985).

Bacterial strains
-----------------

*Staphylococcus aureus* ATCC 25923 and *Escherichia coli* ATCC 25922 were used in these studies. These 2 strains were maintained at −0°C in trypticase soy broth (HBA; Oxoid Ltd., Hampshire, UK) before use in the experiment.

Experimental procedures
-----------------------

To keep the circadian rhythms of the mice identical across the studies, all experiments were conducted at the same time. Mice were weighed and randomly assigned to body weight-matched experimental groups before the experiment. On the experiment day, the mice were separated into 3 treated groups: *S. aureus*, *E. coli*, and PBS (Cambrex, Walkersville, MD, USA). For hematological studies and quantitative determination of inflammatory mediators, separate groups of normal and infected mice were used in a time-course experiment (n=10 mouse/group/time point).

Mouse bloodstream infection model
---------------------------------

*S. aureus* and *E. coli* from frozen stocks were plated on blood agar plates (HBA; Oxoid Ltd., Hampshire, UK). After 24 h of incubation of the agar plates, 1 isolated colony of each strain was transferred to 10 mL of brain-heart infusion broth (HBA; Oxoid Ltd., Hampshire, UK). The broth culture was incubated for 10--12 h at 37°C with continuous shaking. The challenge doses of *S. aureus* and *E. coli* were based on preliminary experiments (data not shown). According to the challenge dose, the broth cultured with *S. aureus* and *E. coli* were diluted to 1×10^8^ cfu/mL and 2×10^9^ cfu/mL in PBS (Cambrex, Walkersville, MD, USA), respectively, to establish a consistent systemic infection mouse model. Male ICR mice weighing between 25 and 27 g were used in these studies. Mice were inoculated with a strain of *S. aureus* or *E. coli* in a final volume of 0.1 mL/10g of PBS by intravenous tail injection. The time of challenge was designated as time 0 of the experiment. Body weight of each mouse used in this study was measured every day at the same time.

Colony-forming units (CFU) analysis
-----------------------------------

To confirm that the infection model in mice was successfully established, the CFU analysis was carried out at 1, 3, 6, and 12 h, as well as 1, 2, 3, 5 and 7 days after *S. aureus* or *E. coli* administration.

Histology studies
-----------------

To assess the host inflammation response of mice to bacterial infection, the liver of each mouse was fixed in 4% neutral formalin solution after being washed with 0.9% NaCl for coronal section with hematoxylin and eosin (H&E) stain.

Mouse WBC counts
----------------

At harvest, whole blood of mice was collected into sterile tubes containing K~2~EDTA for hematological studies. Total peripheral leukocytes were counted by using an automatic hematological analyzer equipped with veterinary software (BC-2800 Vet; Mindray, Shenzhen, China). WBC was determined at 1, 3, 6, and 12 h, as well as at 1, 2, 3, 5, and 7 days after *S. aureus*, *E. coli*, or PBS administration in mice.

Mouse inflammatory mediators
----------------------------

To measure production of inflammatory mediators in serum, whole blood was collected into sterile tubes and these samples were immediately centrifuged at 2000×g for 20 min at 4°C. The serum was then collected into several small tubes, which were stored at −80°C until the day of analysis (within 2 months). Quantitative determination of mouse CRP and PCT in serum was performed by enzyme-linked immunosorbent assays (ELISA), using specific kits for CRP and PCT (USCN, Wuhan, China). We used multi-analyte suspension arrays (MASA; Bio-Plex, Bio-Rad Laboratories, California, USA) for measurement of IL-1α, IL-1β, IL-6, IL-10, monocyte chemotactic protein-1 (MCP-1), and macrophage inflammatory protein-1α (MIP-1α). They utilize color-coded microspheres or beads, laser technology, and high-speed digital signal processing to determine the concentration of cytokines. All samples were analyzed according to the manufacturer's instructions.

Data analysis
-------------

Data were analyzed with SPSS 17.0 (SPSS, Chicago, IL, USA). The normality test of data was performed first; if its distribution was normal, the mean value ± standard deviation (S.D.) was calculated for each treatment group. Data were analyzed by one-way analysis of variance (ANOVA). Student-Newman-Keuls (SNK) post hoc analyses was performed on ANOVA-significant results to analyze the differences in the effect of each treatment. The median, interquartile, and median spacing was determined for abnormal distribution of data for each treatment group. Data are analyzed by non-parametric statistics rank sum test. Integrated areas under the curve (AUC) were calculated by trapezoid analysis and were used to compare the differences in the responses of each mouse to pyrogen and PBS injections \[[@b36-medscimonit-22-161]\]. A *p*-value ≤0.05 was considered statistically significant.

Results
=======

Effects of infection on body weight of mice
-------------------------------------------

To test the infection in mice, body weight of mice was measured every day at the same time ([Figure 1](#f1-medscimonit-22-161){ref-type="fig"}). The mean body weight in the PBS-treated control groups increased throughout the study and was significantly higher than that of the 2 infected groups (*p*\<0.05), and it did not differ between the 2 infected groups.

The CFU analysis
----------------

The number of CFUs in *S. aureus-*infected mouse blood reached a peak in the first few hours after infection, and decreased rapidly after 12 h. The same trend occurred in the *E. coli-*infected mice ([Figure 2](#f2-medscimonit-22-161){ref-type="fig"}).

Liver histology
---------------

Pathological changes in mouse livers were observed visually at 24 h after injection with either *S. aureus* or *E. coli* ([Figure 3](#f3-medscimonit-22-161){ref-type="fig"}). Intravenous infection with either *S. aureus* or *E. coli* for 3 h caused leukocyte margination at the vascular side of the liver ([Figure 4B, 4J](#f4-medscimonit-22-161){ref-type="fig"}). At 6 h after infection, a small number of leukocytes were observed in the liver tissue ([Figure 4C, 4K](#f4-medscimonit-22-161){ref-type="fig"}), and infiltration of many inflammatory cells was observed at 12 h after injection ([Figure 4D, 4L](#f4-medscimonit-22-161){ref-type="fig"}). Small inflammatory lesions appeared in the liver at 1 day after infection with either *S. aureus* or *E. coli* ([Figure 4E, 4M](#f4-medscimonit-22-161){ref-type="fig"}), and more and larger lesions appeared at 2, 3, and 5 days ([Figure 4F--4H, 4N--4P](#f4-medscimonit-22-161){ref-type="fig"}). Seven days after injection, the liver tissues of *S. aureus* or *E. coli* mice were the same as in the normal group.

Levels of WBCs and inflammatory mediators
-----------------------------------------

The kinetics of WBC, CRP, PCT, IL-1α, IL-1β, IL-6, IL-10, MCP-1, and MIP-1α in response to *S. aureus* or *E. coli* infection were studied. Significant differences were found between the production of these mediators in normal and infected mice (*p*\<0.05). [Figure 5](#f5-medscimonit-22-161){ref-type="fig"} A shows the effects of i.v. administration of both bacterial strains on the total counts of white blood cells in mice. The absolute leukocyte count was significantly increased at 12 h after challenge with either *S. aureus* or *E. coli* (*p*\<0.05), and remained elevated until 5 days after injection. High-level secretion of CRP and PCT was observed in sera of both *S. aureus-* and *E. coli-*infected mice ([Figure 5B, 5C](#f5-medscimonit-22-161){ref-type="fig"}). As shown in [Figure 5B](#f5-medscimonit-22-161){ref-type="fig"}, both *S. aureus* and *E. coli* evoked a significantly higher production of CRP in serum of mice at 3 h (*p*\<0.05), and reached a peak at 6 to 12 h after injection. Concentrations of PCT ([Figure 5C](#f5-medscimonit-22-161){ref-type="fig"}) in serum were found to rise at 1 h (*p*\<0.05), reached a peak at 6 to 12 h after injection or either *S. aureus* or *E. coli*, and returned to the pre-injection values at 5 days after challenge. However, unlike WBC, CRP and PCT, the concentrations of IL-1α ([Figure 5D](#f5-medscimonit-22-161){ref-type="fig"}), IL-1β ([Figure 5E](#f5-medscimonit-22-161){ref-type="fig"}), IL-6 ([Figure 5F](#f5-medscimonit-22-161){ref-type="fig"}), IL-10 ([Figure 5G](#f5-medscimonit-22-161){ref-type="fig"}), MCP-1 ([Figure 5H](#f5-medscimonit-22-161){ref-type="fig"}), and MIP-1α ([Figure 5I](#f5-medscimonit-22-161){ref-type="fig"}) in serum were observed to rise at 1 h (*p*\<0.05), and reached a peak at 3 to 6 h after *E. coli* challenge, in contrast to the PBS controls. However, no difference was found between *S. aureus*-treated groups and *E. coli*-treated groups of mice in these inflammatory mediators (*p*\>0.05).

Furthermore, AUC was used to compare the production of inflammatory mediators between *S. aureus*-treated groups and *E. coli*-treated control groups of mice ([Figure 6](#f6-medscimonit-22-161){ref-type="fig"}). The results showed that compared to *S. aureus*, injection of *E. coli* evoked a significant increase in IL-1α ([Figure 6D](#f6-medscimonit-22-161){ref-type="fig"}), IL-1β ([Figure 6E](#f6-medscimonit-22-161){ref-type="fig"}), IL-6 ([Figure 6F](#f6-medscimonit-22-161){ref-type="fig"}), IL-10 ([Figure 6G](#f6-medscimonit-22-161){ref-type="fig"}), MCP-1 ([Figure 6H](#f6-medscimonit-22-161){ref-type="fig"}), and MIP-1α ([Figure 6I](#f6-medscimonit-22-161){ref-type="fig"}) levels in mice. In contrast, levels of WBC ([Figure 6A](#f6-medscimonit-22-161){ref-type="fig"}), CRP ([Figure 6B](#f6-medscimonit-22-161){ref-type="fig"}), and PCT ([Figure 6C](#f6-medscimonit-22-161){ref-type="fig"}) failed to discriminate between *S. aureus* infection and *E. coli* infection (*p*\>0.05).

Discussion
==========

Microbial pathogenic infections have played a devastating role in human history. There is always a need for proper diagnosis of microbial infection and its administration in the field of medical science. The isolation and identification of pathogens are considered as essential procedures for diagnosing bloodstream infection, which is an important step towards limiting morbidity and mortality \[[@b31-medscimonit-22-161]\]. However, blood cultures require at least 24 to 48 h and must be interpreted carefully by experts due to loss of sensitivity and specificity \[[@b32-medscimonit-22-161]--[@b34-medscimonit-22-161]\]. Circulating inflammatory mediators such as PCT, CRP, and IL-6 have been repeatedly evaluated for the accurate and prompt diagnosis of bloodstream infections \[[@b31-medscimonit-22-161],[@b35-medscimonit-22-161]\].

The present study was specifically designed to find inflammatory mediators that differentiate gram-positive from gram-negative infections in order to administer the correct antibiotic therapies. The *S. aureus* and *E. coli* bloodstream infection mouse models were established and confirmed by CFU analysis. The pathologic histology check showed that liver inflammation occurred in the infected mice, and the situation progressively worsened in the first few days, which caused the inflammatory lesions appearing on the liver. The symptom of inflammation was further evidence substantiating the successful establishment of the bloodstream infection mouse models.

The results of the animal experiments demonstrate that an advantage of the serum IL-1α, IL-1β, IL-6, IL-10, MIP-1α, MCP-1, CRP, and PCT detection over blood culture is its rapid performance; it takes only a few hours to perform inflammatory mediator assays, which is significantly quicker than blood culture incubation. Moreover, we found that increased serum IL-1α, IL-1β, IL-6, IL-10, MIP-1α, and MCP-1 can differentiate *E. coli* from *S. aureus* stimuli in mice, but CRP and PCT are not specific mediators to discriminate between *E. coli* and *S. aureus* infections. This suggests that IL-1α, IL-1β, IL-6, IL-10, MIP-1α, and MCP-1 may be able to differentiate gram-positive from gram-negative infections. Although this is unique and of considerable importance, further studies on the contribution of these markers in discrimination between gram-positive and gram-negative infections are necessary to verify these findings. The present knowledge regarding inflammatory mediators in infectious patients is still limited but indicates that the host response to microbial infection is mediated by the release of inflammatory mediators into the bloodstream \[[@b36-medscimonit-22-161]--[@b38-medscimonit-22-161]\]. However, little is known about the mechanism to exclude gram-positive from gram-negative infections by using these circulating inflammatory mediators. In most relevant studies, infections were induced by the major constituent of cell walls of bacteria, like the lipopolysaccharide (LPS, endotoxin) of gram-negative bacteria, and the peptidoglycan or lipoteichoic acid of gram-positive bacteria. The pathogenesis of gram-positive and gram-negative infections induced by living bacteria has not yet been discovered \[[@b3-medscimonit-22-161],[@b39-medscimonit-22-161],[@b40-medscimonit-22-161]\]. Thus, in this study, we used experimental models induced by *S. aureus* and *E. coli* to mimic the pathophysiologic events that possibly occur in patients with bloodstream infection.

To confirm the bloodstream infections, models were successfully established, and we monitored the body weight and performed the histological evaluation of the livers of infected mice. The present results show that the increase in body weight of infected mice was significantly slower than that of the control group. Furthermore, significant indications of inflammatory cells and focus of infection were obvious on the livers of the infected mice. Both the body weight results and the histological evaluation indicate that the bloodstream infection mouse model was successfully established.

The present results indicate that cytokines such as IL-1α, IL-1β, IL-6, IL-10, MIP-1α, and MCP-1 are able to discriminate between *S. aureus* and *E. coli* infection, which confirms previous experimental and clinical studies showing that the production of inflammatory mediators was different between gram-positive and gram-negative infections \[[@b41-medscimonit-22-161]--[@b44-medscimonit-22-161]\]. Several reports showed that the differences in the cytokine pattern responses to gram-positive and gram-negative bacteria may correspond to the different cell surface receptors stimulated by different bacteria \[[@b45-medscimonit-22-161]\]. There is evidence to support that LPS in the gram-positive bacterial cell walls in complex with LPS-binding protein interacts with CD14 and the tri-molecular complex binds to Toll-like receptor 4 (TLR-4), while LAT and peptidoglycan in gram-negative bacteria interact with TLR-2 \[[@b46-medscimonit-22-161]--[@b48-medscimonit-22-161]\].

Conclusions
===========

The present findings illustrate the potential of IL-1α, IL-1β, IL-6, IL-10, MIP-1α, and MCP-1 in distinguishing gram-positive from gram-negative infections. Although further studies using a variety of gram-positive and gram-negative bacteria to verify this hypothesis are still necessary, this study successfully established experimental methods for use in further studies. We will collect more clinical specimens to provide additional evidence to support the diagnostic use of these circulating inflammatory mediators in clinical practice. Our ultimate goal is to provide evidence to guide the choice of specific antibiotic therapies before culture results are available.
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![Body weight of mice. The values presented are the means ± standard deviation (S.D.) for 10 per group. Body weight of mice was determined at the same time of day after i.v. injection of either PBS (■), *S. aureus* (○), or *E. coli* (▲). \*, *p*\<0.05 (significantly different from the control values by one-way analysis of variance).](medscimonit-22-161-g001){#f1-medscimonit-22-161}

![The CFU analysis in blood of infected mice. (**A**) The CFU analysis of mice infected with *S. aureus*; (**B**) The CFU analysis of mice infected with *E. coli*.](medscimonit-22-161-g002){#f2-medscimonit-22-161}

![The gross changes of liver. (**A**) Liver of normal mice; (**B**) Liver of mice at 24 h after administration of *E. coli*; (**C**) Liver of mice at 24 h after administration of *S. aureus.* There was much necrosis in the livers of mice at 24 h after administration of *S. aureus* or *E. coli,* as the arrows indicated.](medscimonit-22-161-g003){#f3-medscimonit-22-161}
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Figure 4A--H. Histological alterations of livers of mice (hematoxylin and eosin stain, ×10). (**A--H**) Livers of mice at 0, 3, 6, 12 h and 1, 2, 3, 5, 7 days after administration of *S. aureus*. **I--P.** Histological alterations of livers of mice (hematoxylin and eosin stain, ×10). Livers of mice at 0, 3, 6, 12 h and 1, 2, 3, 5, 7 days after administration of *E. coli*.
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![(**A--I**) Effects of *S. aureus* and *E. coli* on WBC and serum CRP, PCT, IL-1α, IL-1β, IL-6, IL-10, MIP-1α, and MCP-1 levels in mice. Serum levels of these mediators in separate groups of mice were determined at 0, 1, 3, 6, 12 h and 1, 2, 3, 5, 7 days after i.v. injection of either PBS (■), *S. aureus* (○), or *E. coli* (▲). Each experiment involved 10 mice per time point. At all of the time points tested after injection of PBS (control), mice showed no significant elevation in serum levels of these cytokines (*p*\>0.05). Symbols represent means; bars indicate standard deviation (S.D.). \*, *p*\<0.05 between *S. aureus*- and *E. coli*- injected mice (ANOVA, Student-Newman-Keuls post hoc test) for the same time point.](medscimonit-22-161-g005){#f5-medscimonit-22-161}

![Mean integrated WBC (**A**), CRP (**B**), PCT (**C**), IL-1α (**D**), IL-1β (**E**), IL-6 (**F**), IL-10 (**G**), MIP-1α (**H**), and MCP-1 (**I**) responses of mice after PBS (hatched bars), *S. aureus* (black bars), or *E. coli* (white bars) challenge. Statistical analysis was performed on AUC data from 0 to 168 h after the time of injection and was calculated from the data shown in [Figure 4](#f4-medscimonit-22-161){ref-type="fig"}. Bars represent means ± standard deviation (S.D.) for each group of mice (nd, not detected). \*, statistically significant differences (*p*\<0.05) between *S. aureus*- and *E. coli*- treated mice and their respective PBS-treated groups, respectively. \#, significantly different (*p*\<0.05) from corresponding values between *S. aureus-* and *E. coli-*treated mice (ANOVA, Student-Newman-Keuls post hoc test).](medscimonit-22-161-g006){#f6-medscimonit-22-161}
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